• Magazine
  • ENEWS
  • SUBSCRIBE
  • WEBINARS
  • PODCASTS
  • EBOOKS
    • Feb 28, 2025FDA hits Piramal Pharma’s India API plant with Form 483 | Vaxcyte, Lonza advance pneumococcal vaccine manufacturing
    Feb 27, 2025Eli Lilly invests $27B in US drug manufacturing amid tariff threats | Rovi’s CDMO business lowers 2024 revenue
    Feb 26, 2025Thermo Fisher pays $4.1B for purification, filtration business | FDA sued for taking Ozempic, Wegovy off shortage list
    Feb 25, 2025Celltrion adjusts strategy for potential Trump pharma tariffs | Tiziana partners with Renaissance Lakewood on intranasal drug
    Feb 22, 2025FDA blocks imports from two Indian API makers | Eli Lilly expands manufacturing to boost supply
    Feb 21, 2025Charles River beats Q4 estimates despite CDMO slowdown | LINDIS Biotech taps Celonic for cancer fluid treatment
    Feb 20, 2025Pfizer manufacturing in Europe at risk from tariffs: CEO | Siegfried posts 2024 profit despite challenges
    Feb 19, 2025ICU Medical issues nationwide recall | Sartorius sees demand recovery after challenging 2024
    Feb 18, 2025Rovi’s contract manufacturing slows in Q4 | West Pharma sees sales growth, projects modest 2025 gains
    Feb 15, 2025Trump administration’s NIH cuts threaten biopharma funding | Moderna trims manufacturing, takes $238M Q4 hit
    Feb 14, 2025Axplora invests $52M in GLP-1 production in France | Selkirk Pharma unveils ClinFAST for faster clinical fill-finish
    Feb 13, 2025FDA hits two Chinese API makers with warning letters | Oramed teams with China’s Hefei Tianhui Biotech
    Feb 12, 2025Novartis invests $3.6B in Slovenia | FDA warns Global Calcium, blocks US imports
    Feb 11, 2025Trump tariffs add uncertainty for biopharma FDI | Rentschler Biopharma’s climate goals approved
    Feb 8, 2025Eli Lilly sees returns on $23B manufacturing investment | Uniphar expands in US, Netherlands, Ireland
    Feb 7, 2025Novo Nordisk plans $9B investment in 2025 to boost capacity | Ardena acquires Catalent drug manufacturing facility
    Feb 6, 2025Recipharm launches modular sterile filling system | Jabil acquires Pharmaceutics International to enter CDMO market
    Feb 5, 2025Thermo Fisher to lay off 300 workers at two viral vector plants | Alvogen issues nationwide recall of fentanyl patches
    Feb 4, 2025AstraZeneca scraps $558.3M UK vaccine plant | Catalent, Jupiter partner on Parkinson’s trial
    Feb 1, 2025Avid Bioservices stockholders approve $1.1B buyout | Upperton opens $8.9M sterile facility in Nottingham
    Jan 31, 2025Rentschler exits cell, gene therapy | Celltrion responds to tariff risks
    Jan 30, 2025Lonza’s capsules business dents 2024 results, eyes 2025 rebound | miRecule, GBI Biomanufacturing partner on antibody-RNA therapies
    Jan 29, 2025Lantheus buys radiopharma CDMO for $250M | Indian CDMOs on rise as they boost global competitiveness
    Jan 28, 2025R&D budget, life science tools spending seen mixed in 2025 | Swarm Oncology launches with T cell platform
    Jan 25, 2025Cellipont, Secretome partner on cGMP manufacturing for master cell bank | Scorpius, KaloCyte team on manufacturing for artificial red blood cell
    Latest Edition